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Many genes in Bacillus cereus and Bacillus thuringiensis are under the control of the
transcriptional regulator PlcR and its regulatory peptide, PapR. In Bacillus anthracis, the causative
agent of anthrax, PlcR is inactivated by truncation, and consequently genes having PlcR binding
sites are expressed at very low levels when compared with B. cereus. We found that activation of
the PlcR regulon in B. anthracis by expression of a PlcR–PapR fusion protein does not alter
sporulation in strains containing the virulence plasmid pXO1 and thereby the global regulator
AtxA. Using comparative 2D gel electrophoresis, we showed that activation of the PlcR regulon in
B. anthracis leads to upregulation of many proteins found in the secretome of B. cereus, including
phospholipases and proteases, such as the putative protease BA1995. Transcriptional analysis
demonstrated expression of BA1995 to be dependent on PlcR–PapR, even though the putative
PlcR recognition site of the BA1995 gene does not exactly match the PlcR consensus sequence,
explaining why this protein had escaped recognition as belonging to the PlcR regulon.
Additionally, while transcription of major PlcR-dependent haemolysins, sphingomyelinase and
anthrolysin O is enhanced in response to PlcR activation in B. anthracis, only anthrolysin O
contributes significantly to lysis of human erythrocytes. In contrast, the toxicity of bacterial culture
supernatants from a PlcR-positive strain towards murine macrophages occurred independently of
anthrolysin O expression in vitro and in vivo.
INTRODUCTION
Bacillus cereus and Bacillus anthracis, members of the B.
cereus group of bacteria, have high genetic similarity
(Ivanova et al., 2003; Read et al., 2003), and may even
constitute a single species (Helgason et al., 2000). While B.
cereus is an opportunistic human pathogen (Drobniewski,
1993), B. anthracis is the aetiological agent of anthrax, a
disease with a high lethality in many animal species,
including humans (Mock & Fouet, 2001). The strikingly
different behaviour of these closely related species is
attributed to B. anthracis having several additional genetic
features, such as the virulence plasmids pXO1 and pXO2.
These plasmids encode genes for the anthrax tripartite
toxin, composed of protective antigen (PA), lethal factor
(LF) and oedema factor (EF), and genes for the biosynthetic
enzymes for the antiphagocytic poly-c-D-glutamic acid
capsule (Mock & Fouet, 2001). Another unique genetic
trait involves the pleiotropic transcriptional regulator PlcR
(Agaisse et al., 1999; Lereclus et al., 1996). In B. cereus, PlcR
acts by binding to a well-defined site (the PlcR box),
consisting of a 16 bp consensus sequence present in
promoter regions of PlcR-regulated genes (Agaisse et al.,
1999; Okstad et al., 1999). Furthermore, PlcR action
requires the participation of a secreted, processed and
reimported heptapeptide derived from PapR (Bouillaut
et al., 2008; Lereclus et al., 1996; Okstad et al., 1999; Slamti
et al., 2004). Comparative protein and RNA expression
profiles of PlcR-positive and -negative B. cereus and Bacillus
thuringiensis strains have identified genes regulated by PlcR
that encode collagenases, haemolysins, phospholipases and
enterotoxins (Gohar et al., 2002, 2008; Slamti et al., 2004).
Conversely, in B. anthracis, a nonsense mutation in plcR
results in a premature translational stop (Agaisse et al.,
1999; Slamti et al., 2004), and consequently gene expression
in B. anthracis differs drastically from that in B. cereus.
Certain phenotypic properties of B. anthracis, such as lack
of haemolytic activity towards erythrocytes (Burdon, 1956),
can be attributed to the non-functional PlcR, even
though the genes for at least two haemolysins are present
in the B. anthracis genome. The best-characterized haemo-
lysin of B. anthracis is anthrolysin O, a member of the
Abbreviations: BMDMs, bone marrow-derived macrophages; LF, lethal
factor; LT, lethal toxin; PA, protective antigen.
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lysis of a variety of cells (Mosser & Rest, 2006; Shannon
et al., 2003; Tweten, 2005). Although B. anthracis strains are
non-haemolytic on blood agar plates, this PlcR-dependent
haemolysin is expressed under certain culture conditions as
well as in vivo (Ross & Koehler, 2006; Shannon et al., 2003).
In B. anthracis, studies of the putative PlcR regulon have
been restricted to sequence searches for PlcR boxes and
comparisons with B. cereus, and have resulted in the
identification of about 50 B. anthracis genes that are
potentially subject to regulation by PlcR (Mignot et al.,
2001; Rasko et al., 2005; Read et al., 2003). Several studies
report the activation of the PlcR regulon in B. anthracis
(Mignot et al., 2001; Pomerantsev et al., 2003, 2004). One
study shows that expression of PlcR in B. anthracis affects
sporulation of bacteria containing the virulence plasmid
pXO1, but not of bacteria lacking either pXO1 or the pXO1-
encoded regulator AtxA alone, and it has been hypothesized
that in B. anthracis, functional PlcR is incompatible with
AtxA-controlled gene regulation (Mignot et al., 2001).
However, subsequent reports have described haemolytic B.
cereus strains having pXO1-like plasmids (Hoffmaster et al.,
2004, 2006; Klee et al., 2006), and a recent report describes
the presence of two AtxA homologues in a B. cereus strain
containing an active PlcR regulator (Passalacqua et al.,
2009). These observations motivated us to readdress the
hypothesis that AtxA cannot coexist with an active PlcR
system. We have previously shown that the haemolytic
activity of B. anthracis can be drastically increased upon
introduction of plasmid pFP12 containing a PlcR–PapR
fusion protein, leading to growth phase-independent
activation of the PlcR regulon in B. anthracis. This fusion
protein contains a full-length PlcR fused to PapR after
deletion of the stop codon and one of three repetitive MKK
motifs (Pomerantsev et al., 2004). In this study, using
plasmid pFP12, we investigated the effect of a functional
PlcR regulon in B. anthracis with regard to sporulation,
protein expression, anthrolysin-dependent haemolysis, and
toxicity towards macrophages in vitro and in vivo.
METHODS
Bacterial strains, media and growth conditions. Table 1 lists all
strains and plasmids used in this study. Bacteria were routinely grown
in Luria–Bertani (LB), Brain–Heart Infusion (BHI; BD Biosciences)
or nutrient broth with yeast extract (NBY) containing 0.8% nutrient
broth (Sigma), 0.3% yeast extract, 9% heat-inactivated equine serum
(Hyclone), and 0.6% NaHCO3 at 37 uC and 225 r.p.m. in either air
or air supplemented with CO2 regulated at 5% for media
supplemented with NaHCO3. AtxA functionality was tested for
bacteria grown in NBY broth. Spores were prepared as described
previously (Sastalla et al., 2009). For haemolytic studies, bacteria were
grown on tryptic soy agar with 5% sheep blood (both BD
Biosciences) or BHI broth. When required, the following antibiotics
were added to Escherichia coli or B. anthracis cultures: ampicillin
(100 mgm l
21), erythromycin (10 mgm l
21), kanamycin (20 mgm l
21),
tetracycline (10 mgm l
21) and spectinomycin (150 mgm l
21). All
antibiotics were purchased from Sigma.
DNA techniques and mutagenesis. For generating an anthrolysin
knockout strain, two alo-adjacent fragments were amplified using
primers ALL and ALR (fragment aloLF), and primer ARL in
combination with ARR (fragment aloRF), harbouring EcoRI and
SpeI sites, respectively (Table 1). Amplified fragments were separately
cloned into vector pSC, a plasmid allowing sequential generation of
markerless deletions using the Cre/Lox system (Pomerantsev et al.,
2009). Briefly, plasmid pSC-aloLF was introduced into B. anthracis;
electrocompetent cells were prepared as described previously (Park &
Leppla, 2000). Transformants were selected at 30 uC on erythromycin
and chromosomal integration of the plasmid was achieved by a
temperature shift to 37 uC. Plasmid pCrePAS was introduced,
resulting in excision of the inserted plasmid backbone by Cre-
recombinase activity, leaving a single loxP site. Plasmid pSC-aloRF was
introduced and the 30 uC/37 uC selection cycle followed by introduc-
tion of pCrePAS was repeated, resulting in excision of residual vector
and the entire alo gene from the bacterial chromosome.
Plasmid pFP12 (Pomerantsev et al., 2004) was introduced by
electroporation. To verify the presence (i.e. retention) of pXO1 in
B. anthracis, bacteria were resuspended in Tris/EDTA buffer (Quality
Biological), boiled for 2 min, and supernatants were used as template
for the PCR using Taq polymerase (Qiagen) and PA (pagA) gene
primers PA1 and PA2 (Table 1). For sequencing of atxA, primers
AtxSeq1 and AtxSeq5 generated a 1742 bp PCR product that was
subsequently used as template for sequencing reactions using primers
AtxSeq1, AtxSeq2, AtxSeq3, AtxSeq4 and AtxSeq5.
Sporulation efficacy. Bacteria were grown on sporulation agar
(Sastalla et al., 2009) for 5 days, analysed microscopically using a
Nikon Eclipse TE200U microscope, scraped off the plates, and
resuspended in 1 ml sterile distilled water. Spore suspensions were
heat-treatedat65 uC for30 min andplatedonLBagar.Thepercentage
of viable spores was calculated using the following equation:
(c.f.u. after heat treatment/c.f.u. before heat treatment)6100
2D SDS-PAGE and protein identification. Bacteria were grown to
the late exponential/early stationary growth phase and centrifuged at
9000 g, and filter-sterilized supernatants were precipitated with TCA
(10% final concentration), washed in ice-cold acetone and resus-
pended in 2D-rehydration buffer [8 M urea, 2% (w/v) CHAPS, 0.5%
(v/v) ZOOM carrier ampholytes for pH range 3–10 (Invitrogen),
0.002% bromophenol blue, 20 mM DTT]. Proteins were quantified
using 2D Quant (Amersham), and 50 mg was separated on a NuPAGE
gel using the IPG Runner system (Invitrogen) according to the
manufacturer’s recommendations. Gels were Coomassie-stained and
spots of interest were excised, trypsin-digested and analysed by MS.
Retrieved data were searched against the B. anthracis Ames strain
database using Mascot as the search engine. Peptides with a Mascot
protein score higher than 60 were considered significant, and the
most abundant protein present in each spot is listed in Table 2. MS-
MS analysis was performed at the National Institute of Allergy and
Infectious Diseases (NIAID) Research Technology Branch (RTB)
Core Facility. Protein alignments and sequence analyses were
performed using Lasergene MEGALIGN, PSORTb (Gardy et al., 2005),
SignalP (Emanuelsson et al., 2007), Prosite (http://expasy.org/prosite)
and TMpred (http://www.ch.embnet.org).
Western blotting. Filter-sterilized supernatants of bacterial cultures
grown in NBYmedium tostationaryphase wereseparated onNuPAGE
gels (Invitrogen) and blotted onto nylon membranes (Osmonics).
Membranes were incubated with 2 mg mouse monoclonal antibo-
dies ml
21 against either PA (PA-05-A-G1) or LF (LF-03-A-G1) (both
from the Naval Medical Research Center) in 1% skim milk, and
anti-mouse IgG conjugated to horseradish peroxidase (KPL) was used
as secondary antibody. Membranes were developed using a tetra-
methylbenzidine (TMB) peroxidase substrate (KPL).
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exponential/stationary phase were centrifuged, and RNA was sta-
bilized using RNA Protect Bacteria reagent (Qiagen) before further
isolation using a Qiagen RNeasy kit. Further preparation of RNA and
RT-PCR was performed as described previously (Sastalla et al., 2009).
To amplify targeted mRNAs, the following oligonucleotides were
used: primers BA1995fw in combination with BA1995rv, primers
Sph1 and Sph2, and primers Alo1 and Alo2 (Table 1). Internal control
reactions were performed with primers GyrAfw and GyrArv as des-
cribed previously (Sastalla et al., 2009). Band intensities were
quantified using ImageJ version 1.40 g.
Haemolytic assays. Human blood obtained from the National
Institutes of Health (NIH) Blood Bank was washed with PBS and
resuspended in PBS to the original volume. A 40 ml volume of blood
was mixed with 160 ml culture supernatant obtained from bacteria
grown in BHI medium to which 20 mM cysteine had been added,
incubated at 37 uC for 45 min and centrifuged at 500 g, and the A540
of supernatants was measured in a SpectraMAX 190 plate reader
(Molecular Devices). A haemolysis value of 100% corresponded to
haemolysis obtained by addition of 0.1% SDS in BHI broth. For some
experiments, cholesterol at a final concentration of 25 mM was added.
Preparation and use of bone marrow-derived macrophages
(BMDMs). Bone marrow cells from 8–14-week old DBA/2J mice
(Jackson Laboratories) were cultured in two parts complete Dulbecco’s
modified Eagle’s medium (DMEM) [10% fetal bovine serum (FBS),
10 mM HEPES, 50 mg gentamicin ml
21] and one part L929 cell culture
Table 1. Bacillus strains, plasmids and primers used in this study
Restriction sites are underlined.
Strain, plasmid or primer Relevant characteristic(s) Source or reference
B. anthracis strains
Sterne 34F2 pXO1
+, PlcR
2
SdT 34F2, pXO1
2, PlcR
2 Ivins et al. (1986)
SdT12 34F2, pXO1
2, harbouring pFP12, PlcR
+ Pomerantsev et al. (2004)
Sterne pFP12 34F2 harbouring pFP12, PlcR
+ (pXO1
+) This study
Sterne DALO 34F2, anthrolysin-negative (pXO1
+) This study
Sterne DALO pFP12 34F2, anthrolysin-negative, harbouring pFP12,
PlcR
+ (pXO1
+)
This study
B. cereus strain
569 Reddy et al. (1987)
E. coli strains
TOP10 Invitrogen
XL2-Blue Stratagene
SCS110 Stratagene
Plasmids
pFP12 Encodes a PlcR–PapR fusion protein Pomerantsev et al. (2004)
pSC Contains loxP site for B. anthracis mutagenesis Pomerantsev et al. (2009)
pSC-aloLF pSC with ALL and ALR-derived amplicon This study
pSC-aloRF pSC with ARL and ARR-derived amplicon This study
pCrePAS Contains Cre recombinase Pomerantsev et al. (2009)
Primers Sequence (5§–3§) Relevant property
ALL ccccgaattcagaagcagaaagccccgcat Amplification of aloLF
ALR ccccactagtcggcttgtgtttctgcaaaa
ARL ccccgaattcttgcatgggaatggtggaga Amplification of aloRF
ARR ccccactagttgcccccaaatagacttcaa
PA1 gattcaggcagaagttaaacagg Amplification of pagA
PA2 cccaccaatatcaaagaacg
AtxSeq1 tgctatttcaatagaagaaacaaaaa Used to sequence AtxA
AtxSeq2 tccaagatggaggaatttcg
AtxSeq3 tgcaatccttagctcaaaactc
AtxSeq4 cctttggctaaagaaattacc
AtxSeq5 tatccatcgctatgcaggtg
BA1995fw cgcgtcatctgtatcttatgc Used for BA1995 RT-PCR
BA1995rv agcttgtccatttcctgtgc
Sph1 tatccgaattggggacaaag Used for sph RT-PCR
Sph2 gaagcgtgcaatgttttgaa
Alo1 tgtggctggagcagtagatg Used for alo RT-PCR
Alo2 cactcgtttcgacgctgtta
GyrAfw aaaacctgtgcatcgtaggg Used for gyrA RT-PCR
GyrArv acattagcattggcatcacg
I. Sastalla and others
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free DMEM, and 80 ml aliquots were transferred to 96-well microtitre
plates. Filter-sterilized bacterial culture supernatants (25 ml) harvested
from BHI-grown bacteria were added, and plates were incubated for
4 h at 37 uC and 5% CO2. For some experiments, supernatants were
heat-treated at 95 uC for 10 min before addition to cells. To determine
the viability of cells, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazo-
lium bromide (MTT; Sigma) was added at a final concentration of
1m gm l
21, and pictures of the stained (viable) cells were taken after
incubation for 45 min at 37 uCi n5%C O 2. The amount of formazan
produced by viable cells was quantified at 590 nm after removal of
medium and addition of 50 ml dissolving buffer containing 0.5% SDS
and 25 mM HCl dissolved in 90% 2-propanol.
Intraperitoneal treatment of mice and isolation of cells. DBA/2J
mice (8–14 weeks old, n52 in at least three independent studies)
received intraperitoneal injections of 500 ml filter-sterilized bacterial
culture supernatants or BHI alone. After an incubation period of
45 min, intraperitoneal lavages were performed with PBS containing
1% BSA (PBSA). For some experiments, digital images of lavage
samples were taken, or samples were centrifuged, treated twice with
ammonium chloride lysing buffer (ACK; Invitrogen) to eliminate red
blood cells, washed two more times with PBSA, and resuspended in
600 ml of the same buffer. Animal experiments described in this and
the previous section were performed according to NIH and Animal
Welfare Act guidelines and approved by the Animal Care and Use
Committee of the National Institute of Allergy and Infectious
Diseases, National Institutes of Health.
Flow cytometry analyses. Cell suspensions in PBSA were incubated
with rat anti-mouse CD32 antibodies (BD Biosciences) for blocking
of the Fc receptor, followed by allophycocyanin (APC)-conjugated
anti-mouse F4/80 (AbD Serotec) to label macrophages. After
incubation for 30 min at 4 uC, cells were washed with PBSA and
subjected to flow cytometric analysis using an LSR II flow cytometer
(BD Biosciences). Data were analysed either in DIVA software (BD
Biosciences) or in FlowJo version 7 (Tree Star).
Statistics. A t test or one-way ANOVA was performed for unpaired
data (sporulation efficacy and macrophage retrieval from mice), and a
paired t test was performed for paired data (cholesterol inhibition and
in vitro treatment of macrophages with heat-inactivated/non-heated
supernatant) in GraphPad Prism version 5.01.
Table 2. Proteins identified by 2D gel electrophoresis
Gene ID Description Loc.* Mr pI
B. anthracis
BA0885 S-layer protein SAP CW 86.6 7.6
BA0887 S-layer protein EA1 CW 91.4 5.8
BA0796 Conserved hypothetical protein E 40.8 9.6
BA1449 Peptidase, M23/M37 family E 46.2 6.7
BA1952 NLP/P60 family protein CW 43.9 10.2
B. anthracis
pFP12
BA0267 GroEL, 60 kDa chaperoninD C 57.4 4.5
BA0555 Putative collagenaseD E 109.9 5.0
BA0620 Putative 8-amino-7-oxononanoate synthase C 43.1 5.7
BA0670 Putative transaldolase C 23.1 5.3
BA0672 InhA metalloproteaseD E 87.9 5.7
BA0677 Phospholipase CDd E 32.4 7.9
BA1887 EnterotoxinDd E 43.6 4.8
BA1995 Putative proteaseDd E 43.9 9.0
BA2032 Hypothetical proteind E 16.2 8.9
BA3162 Putative 59-nucleotidaseD C 57.8 6.5
BA3891 Phosphatidylinositol diacylglycerol-lyaseDd E 38.1 7.9
BA3962 Ribosome recycling factor C 20.7 5.5
BA3964 Translation elongation factor Ts C 32.4 5.0
BA4181 Pyruvate dehydrogenase complex E3 component,
dihydrolipoamide dehydrogenaseD
C 49.5 5.0
BA4184 Pyruvate dehydrogenase complex E1 component, alpha subunit C 41.4 5.6
BA4194 Putative 2,3,4,5-tetrahydropyridine-2-carboxylate N-
succinyltransferase
C 25.7 5.2
BA4499 Superoxide dismutase, MnD E 22.7 5.3
BA5130 Phosphoglucose isomerase C 50.3 4.8
BA5364 EnolaseD C 46.4 4.4
BA5470 Sulfatase MA 73.5 6.4
BA5580 Fructose-bisphosphate aldolase, class II C 30.7 4.8
*Cellular location: C, cytoplasmic/unknown; CW, cell wall; MA, membrane-associated; E, extracellular.
DProtein found in supernatants of B. cereus.
dPlcR box present.
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AtxA regulation does not interfere with
sporulation in B. anthracis expressing PlcR–PapR
We readdressed the hypothesis that expression of func-
tional PlcR is incompatible with pXO1-encoded, AtxA-
controlled gene regulation. Expression of the PlcR–PapR
fusion protein encoded by plasmid pFP12 (Pomerantsev
et al., 2004) in B. anthracis strain Sterne 34F2 resulted
in colonies that were highly haemolytic on blood agar
plates (Fig. 1a). Microscopic analyses of the parental and
PlcR–PapR-positive (Sterne pFP12) strains surprisingly
showed that both strains readily formed spores (Fig. 1b).
Quantification of sporulation efficacy verified that both
strains sporulated with similar high efficacies (Fig. 1c).
Growth of B. anthracis at elevated temperatures (above
43 uC) can induce loss of the virulence plasmid pXO1
(Mikesell et al., 1983). To exclude the possibility that pXO1
was lost during growth, we verified the presence of pXO1
by PCR using oligonucleotides specific for the PA gene
(pagA) (data not shown).
To determine whether a point mutation in the atxA gene
could have caused inactivation of the regulator, we
sequenced the entire atxA gene in Sterne 34F2 and Sterne
pFP12. The sequences were 100% identical to the annotated
Sterne atxA sequence (data not shown), including 470 bp of
the upstream promoter region, thereby excluding the
possibility that AtxA expression in the PlcR–PapR-positive
strain was silenced by mutation.
To rule out the possibility that other unrecognized changes
may have inactivated AtxA regulation, we investigated the
functionality of AtxA in both the wild-type and pFP12-
containing strains. It has been established that expression
of B. anthracis toxin genes is enhanced by elevated
bicarbonate/CO2 (Leppla, 1988). This higher expression
requires AtxA, even though transcription of the regulator
itself is not affected by bicarbonate/CO2 levels (Dai &
Koehler, 1997). Analysis of PA and LF expression in Sterne
and Sterne pFP12 grown in the presence of bicarbonate/
CO2 showed that both toxins are expressed at similar levels
in both strains, verifying that AtxA is functional in both
strains (Fig. 1d). These results show that strain Sterne 34F2
is able to sporulate when PlcR–PapR and AtxA are
simultaneously active, and that there is no incompatibility
of these two regulators, at least in the strains we
investigated here.
Activation of the PlcR regulon in B. anthracis
leads to expression of proteins found in the
secretome of B. cereus
While the secretomes of B. cereus and B. thuringiensis are
highly similar, B. anthracis shows a distinctively different
secretome, probably due to the presence of an inactive PlcR
(Chitlaru et al., 2006; Gohar et al., 2002). Thus, we assessed
the influence of heterologous PlcR–PapR activation in B.
anthracis on the composition of the bacterial secretome by
2D SDS-PAGE. Fig. 2 shows that the PlcR-expressing B.
anthracis derivative has a secreted protein profile distinc-
tively different from that of wild-type B. anthracis.W e
selected proteins that appeared unique for MS analysis
(Fig. 2, Table 2). We found S-layer proteins SAP/EA1 to be
highly abundant in B. anthracis lacking PlcR–PapR, indi-
cating either lower expression or degradation by PlcR-
regulated proteases. We identified several proteins found
in supernatants of B. cereus, including homologues of an
enterotoxin component (BA1887), phospholipases (BA3891
and BA0677), InhA metalloprotease (BA0672) and a puta-
tive protease (BA1995). A protein of unknown function
Fig. 1. Characterization of PlcR–PapR-expressing strains. (a)
Haemolysis on sheep blood agar by Sterne strain and Sterne
expressing PlcR–PapR. (b) Microscopic analysis of spores formed
by Sterne and the isogenic PlcR–PapR-expressing strain. (c)
Efficacy of sporulation. Shown are mean±SD from one represent-
ative experiment out of three. (d) Western blot analysis of AtxA
activity by determining PA and LF expression in response to
bicarbonate/CO2. Control (CTR) bands represent 1 mg recom-
binant protein.
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anthracis, and interestingly the gene is present in all B.
anthracis strains sequenced to date, but in only four of the
sequenced B. cereus strains (W-8, AH820, E33L and 95/8201).
Analysis of the upstream regions of allidentified proteins fora
putative PlcR binding site showed that five of them indeed
harboured a PlcR box (Table 2). These results demonstrate
the effect that activation of the PlcR regulon has on the
expression profile of B. anthracis, and show that expression of
a PlcR–PapR fusion protein causes the secretome of B.
anthracis to acquire similarities to that of B. cereus.
Expression of the putative protease BA1995 is
enhanced by PlcR–PapR
One difference between the two B. anthracis secretomes
examined inFig.2wasa proteinbandof40–50 kDa that was
highly abundant only in the PlcR–PapR-positive strain (Fig.
2). MS identified this as the putative protease BA1995, and
matched peptides from the analysis are shown in Fig. 3(a).
This protein belongs to the transglutaminase-like superfam-
ily (PFAM 01841) and a homologue is present in B. cereus
(BC1991).PlcR boxhomology searcheshadfailedtoidentify
BA1995 and BC1991 as likely to be regulated by PlcR, but
our data suggested that BA1995 production might be either
directlyorindirectlyregulatedbyPlcR.Quantification ofthe
BA1995 gene transcript in these two strains relative to the
housekeeping gene gyrA showed the amount of transcript
for BA1995 to be about eightfold higher in the pFP12-
containing strain than in the wild-type, indicating that PlcR
can regulate this gene (Fig. 3b). Interestingly, even though
the wild-type strain does not have a functional PlcR, low
levels of BA1995 mRNA were observed, indicating weak
transcription independent of PlcR.
Examination of the region upstream of the BA1995 gene
identified a near-perfect PlcR box 82 bases upstream of the
start codon (Fig. 3c). The sequence differed from the con-
sensus sequence by a residue that is generally conserved.
The region upstream of the B. cereus BC1991 gene showed
the same deviation from the consensus, which might
explain why previous sequence searches failed to identify
this gene as being PlcR-dependent.
In B. anthracis, transcription of the cytolysins
sphingomyelinase and anthrolysin is induced by
PlcR–PapR
The genome of B. anthracis encodes fewer active
haemolysins than that of B. cereus.T h eg e n e sf o r
sphingomyelinase (sph) and anthrolysin (alo) are intact,
whereas the homologues of B. cereus haemolysins II (hlyII)
and III (hlyIII) are truncated (Klichko et al., 2003).
Phospholipase C (PC-PLC; BA0677), which we were able
to detect in culture supernatants of B. anthracis having an
activated PlcR regulon (Fig. 2), is non-haemolytic on its
own (Beecher & Wong, 2000). In B. cereus,t h esph and clo
genes are regulated by PlcR (Gohar et al., 2008; Lereclus
et al., 1996; Pomerantsev et al., 2004; Slamti et al., 2004),
and we confirmed that expression of PlcR–PapR in B.
anthracis results in a haemolytic phenotype. To determine
the contribution of each haemolysin, we measured mRNA
levels at different time points during growth. In the
absence of PlcR, only weak expression of sphingomyeli-
nase and anthrolysin was observed (Fig. 4a). However,
constitutive expression of the PlcR–PapR fusion pro-
tein greatly enhanced transcription of both haemolysins
in the wild-type Sterne strain (Fig. 4a). These results
show that both haemolysins are transcribed in the
Fig. 2. 2D SDS-PAGE separation of proteins secreted by Sterne and Sterne pFP12 grown in BHI broth to late exponential
phase. Boxed spots indicate proteins identified by MS. Proteins are numbered according to B. anthracis Ames (BA) gene ID.
See Table 2 for gene descriptions. Molecular mass (in kDa) is given on the left and the pH range is indicated at the top.
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wild-type strain.
PlcR–PapR-expressing B. anthracis lyses human
red blood cells, with anthrolysin being the main
contributor
Although B. anthracis is considered non-haemolytic
(Burdon, 1956), it has been reported that growth in rich
medium causes anthrolysin production that leads to
haemolysis (Shannon et al., 2003). To further evaluate
the contribution of anthrolysin to haemolysis, we gener-
ated an anthrolysin gene knockout mutant of the Sterne
strain and investigated the haemolytic behaviour towards
human erythrocytes before and after introduction of
pFP12. Supernatants of the pFP12-containing strain were
highly haemolytic throughout the growth cycle (Fig. 4b).
Supernatants of the PlcR–PapR-negative wild-type strain
Fig. 3. Identification and analysis of the PlcR-dependent protease BA1995. (a) Putative protease BA1995 identified by 2D SDS-
PAGE in supernatants of Sterne pFP12. Matched peptides are shown in bold type. (b) Semiquantitative RT-PCR of BA1995
transcription in response to PlcR–PapR expression (lower band). The gene for gyrase A (gyrA) served as internal control. Fold
change indicates gyrA-normalized differences in BA1995 transcript between Sterne and Sterne pFP12. (c) Sequence comparisons
of thePlcRboxpresentin thepromoter regionofBA1995 of B.anthracis strain Ames and thehomologueBC1991 in B. cereus.T h e
PlcR consensus sequence is indicated. The nucleotide differing from the consensus is shown in bold type, nucleotides differing
between B. cereus and B. anthracis are shaded, and putative ”10, ”35 regions and the start codon (ATG) are indicated.
Fig. 4. Transcription and expression of hae-
molysins in PlcR–PapR-expressing B. anthra-
cis. (a) Semiquantitative RT-PCR of B.
anthracis putative haemolysins anthrolysin
(alo) and sphingomyelinase (sph) in response
to PlcR–PapR expression in Sterne and Sterne
pFP12. Transcript levels of bacteria harvested
at different growth phases were compared
with those for gyrase A (gyrA). exp.,
exponential; stat., stationary. (b) Haemolytic
activity (as a percentage) towards human
erythrocytes of bacterial supernatants derived
from Sterne or anthrolysin knockout mutant
(Alo) in the presence or absence of PlcR–
PapR. Supernatants were harvested at differ-
ent OD600. Shown are mean±SD from one
representative experiment out of three. $,
Sterne; &, Sterne pFP12; m, Alo; ., Alo
pFP12. (c) Haemolytic activity (%) of bacterial
supernatants in the presence or absence of
25 mM cholesterol. Shown are mean±SD from
one representative experiment out of three.
I. Sastalla and others
2988 Microbiology 156showeda muchlowerdegreeofhaemolysis thatwasobserved
only after the onset of stationary phase. In contrast, the
anthrolysin knockout strain did not show haemolysis at any
point in the growth cycle, and expression of PlcR–PapR in
the anthrolysin knockout led to only a very low level of
haemolysis (1.9%±0.05). Complementation of the knock-
out by expressing alo on a plasmid under the control of the
PA promoter restored haemolysis to the level seen for the
Sterne pFP12 transformant (data not shown).
Anthrolysin is a cholesterol binding haemolysin, and addition
of cholesterol inhibits its activity (Tweten, 2005). Cholesterol
strongly blocked haemolysis by both wild-type Sterne and
the pFP12-containing strain (Fig. 4c). No haemolysis was
observed for the anthrolysin knockout, and expression of
PlcR–PapR in this mutant could not restore the high
haemolytic phenotype observed for Sterne pFP12 in the
absence of cholesterol. The small residual haemolytic activities
of about 3% seen for both the PlcR–PapR-positive anthrolysin
knockout and the PlcR–PapR-positive anthrolysin-containing
strain show thatotherPlcR-dependenthaemolysinscontribute
only slightly. In summary, these results demonstrate that
anthrolysin is the main contributor to haemolysis of human
erythrocytes by PlcR–PapR-positive and -negative B. anthracis
and that other PlcR-regulated haemolysins, such as sphingo-
myelinase, have a negligible effect.
Supernatants of PlcR–PapR-positive B. anthracis
kill BMDMs in an anthrolysin-independent
manner
In vitro, recombinant anthrolysin lyses a variety of cells,
including human leukocytes, monocytes and lymphocytes
(Mosser & Rest, 2006). We investigated whether anthrolysin
contributes to macrophage toxicity, and for comparison
included culture supernatants derived from a B. cereus
strain. To exclude the known cytotoxic effects caused by
lethal toxin (LT) on certain macrophages, BMDMs from
LT-resistant DBA mice (McAllister et al., 2003) were used.
Macrophages treated with B. cereus culture supernatants
were efficiently lysed, as seen by the lack of purple formazan
when compared with cells treated with medium alone
(Fig. 5a), and surprisingly, culture supernatants derived
from the PlcR–PapR-negative Sterne and anthrolysin-
deficient strains were non-toxic (Fig. 5a, b). Treatment of
BMDMs with culture supernatants from pFP12-containing
bacteria, however, resulted in death of about 50% of
macrophages(Fig. 5b).Heattreatmentof supernatants prior
to incubation with BMDMs abolished the cytotoxic effect
(Fig. 5b). These data show that PlcR-dependent proteins
other than LT and anthrolysin are responsible for the
observed killing.
Intraperitoneal toxicity of PlcR–PapR-positive B.
anthracis is not dependent on anthrolysin
Since the PlcR–PapR-positive B. anthracis supernatants
efficiently killed murine macrophages in an in vitro setting,
we hypothesized that similar cytotoxicity might occur in
vivo. Mice having LT-resistant macrophages were injected
intraperitoneally with cell-free culture supernatants derived
from various strains. After 45 min, peritoneal contents
were collected by lavage. Interestingly, in mice that received
injections of supernatants from PlcR–PapR-positive bac-
teria, we observed intraperitoneal bleeding, as indicated by
the presence of erythrocytes (Fig. 6a). This haemorrhaging
was highly reproducible and was never detected following
injection of supernatants derived from PlcR–PapR-negative
bacteria. We also observed this bleeding when B. cereus-
derived supernatants were injected (results not shown).
The specific cell populations present in the peritoneal
washes were assessed by flow cytometry. Two cell
populations were missing in the peritoneal washes derived
from mice that received injections of supernatants from
PlcR–PapR-positive, but not from PlcR–PapR-negative,
strains (Fig. 6b). Closer characterization of cell populations
using an antibody that binds to the macrophage-specific
F4/80 receptor identified the two missing populations as
macrophages (Fig. 6c). Quantification of F4/80-positive
cells showed a significant (P,0.0001, one-way ANOVA
and P,0.05 Tukey test) fivefold reduction in the numbers
of macrophages retrieved from mice that received pFP12-
containing B. anthracis culture supernatants (Fig. 6d). In
concurrence with in vitro results, this reduction does not
appear to depend on anthrolysin, since macrophages
were also depleted when the anthrolysin gene was absent
(Fig. 6b–d). The toxicity appears to depend on one or more
proteins, since heat treatment of supernatants prior to
injection completely abolished cytotoxicity (results not
shown).
DISCUSSION
Besides the presence of the two large virulence plasmids,
truncation of the major regulator PlcR is one of the major
differences setting B. anthracis apart from other members
of the B. cereus group (Kolstø et al., 2009). The nonsense
mutation leading to truncation of the PlcR protein is
identical in all B. anthracis isolates so far investigated,
thereby strongly suggesting that it is a distinctive and
defining trait of this species (Slamti et al., 2004). Inactiva-
tion of PlcR has a major effect on protein expression
(Gohar et al., 2002) in B. cereus; however, little is known
about the PlcR regulon in B. anthracis, including the
identity of genes that retain the potential to be activated by
PlcR. To elucidate the role of PlcR in B. anthracis,w e
expressed an active PlcR–PapR hybrid protein from a
plasmid (Pomerantsev et al., 2004), thereby activating the
latent PlcR regulon. An earlier study suggested that expres-
sion of PlcR in B. anthracis leads to interference with the
pXO1-dependent AtxA regulon, as indicated by the inabi-
lity of bacteria harbouring both regulators to sporulate
(Mignot et al., 2001). Surprisingly, the B. anthracis strain
containing both regulators that we describe here readily
formed spores. This finding deserves further study in
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manner different from that of the fusion protein encoded
by pFP12.
We also compared the secretomes of PlcR–PapR-expres-
sing strains with those of their PlcR–PapR-negative
counterparts. The secretomes of B. anthracis having active
or inactive PlcR were distinctively different, and in the
former we identified five proteins harbouring a PlcR
binding site in their promoter region. It is likely that
analysis of all protein spots present in the secretome of
PlcR-active B. anthracis would have identified even more
such proteins. Furthermore, we detected many proteins in
the secretome of PlcR-expressing B. anthracis that are
found in culture supernatants of PlcR-active B. cereus
(Gohar et al., 2002, 2005). For example, the B. cereus
homologue of the putative protease BA1995 was present in
supernatants of PlcR-expressing B. anthracis, but absent in
supernatants derived from the PlcR-negative parent strain.
The database annotations available for BA1995 note
similarities to a transglutaminase-like protease (Makarova
et al., 1999), although the function of the protein is
unknown. Our hypothesis that this protein is dependent on
PlcR was confirmed by semiquantitative RT-PCR. Closer
analysis of the BA1995 promoter region revealed a PlcR
box having one mismatch at position 11, resulting in the
exchange of a highly conserved nucleotide. The protease
InhA2 of B. thuringiensis also shows an aberrant PlcR
consensus sequence (Fedhila et al., 2003), and the effect of
base exchanges within the PlcR box on regulator-
dependent activity has been investigated. It was found that
mutations within the PlcR consensus lead to lower
transcription depending on their location (Gohar et al.,
2008). However, the substitution that we identified in the
BA1995 PlcR box was not included in the earlier study. Our
results showing that BA1995 is still transcribed at a low
level in the absence of PlcR imply that changes in the more
conserved residues lower the specificity of PlcR for its
target sequence, as shown by Gohar et al. (2008).
Additionally, the ability of PlcR to recognize an aberrant
recognition sequence suggests that the PlcR regulon is
larger than anticipated.
One striking phenotype of bacteria harbouring a functional
PlcR is their haemolytic behaviour on blood agar plates.
PlcR–PapR-expressing bacteria were clearly haemolytic, and
anthrolysin, the best-characterized haemolysin of B.
anthracis (Mosser & Rest, 2006; Shannon et al., 2003), was
found to be the main contributor, causing lysis of human
erythrocytes in PlcR-positive and -negative bacteria.
Although sphingomyelinase is transcribed at a low level,
its contribution to haemolysis of human erythrocytes
appears to be negligible. However, the content of sphingo-
myelin in the membrane of human red blood cells is low
when compared with other species. In sheep, sphingomyelin
can make up to 50% of the phospholipids present in the red
blood cell membrane (Ikezawa et al., 1980); therefore, for
detection of sphingomyelinase activity, erythrocytes of
other species are expected to be a better indicator.
Macrophages are key players during anthrax pathogenesis,
functioning as vehicles for transport of phagocytosed
Fig. 5. In vitro toxicity towards macrophages of proteins secreted by Bacillus. (a) MTT stain of BMDMs treated for 4 h with cell-
free bacterial culture supernatants derived from late exponential phase B. cereus BC569 (a2), B. anthracis (a3), B. anthracis
pFP12 (a4), B. anthracis anthrolysin knockout (a5), B. anthracis anthrolysin knockout harbouring pFP12 (a6), and broth-treated
control (N.T.) (a1). (b) Quantification of surviving macrophages treated with bacterial culture supernatants before (N.T.; grey
bars) and after (H.I.; black bars) heat treatment at 95 6C for 10 min. Shown are mean±SD from one representative experiment
out of three.
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have shown that recombinant anthrolysin and supernatants
derived from B. anthracis are able to kill a variety of cells,
including macrophages derived from peripheral human
blood. Surprisingly, we found no toxic response in macro-
phages treated with supernatants from B. anthracis Sterne.
However, the final concentration of 25% supernatant in our
cell assay may be lower than the concentrations used by
Mosser & Rest (2006). In contrast, macrophages treated in
vitro and in vivo with culture supernatants derived from
PlcR–PapR-expressing bacteria were killed, and deletion of
anthrolysin expression did not have an effect, indicating that
toxin(s) other than anthrolysin were responsible for the
killing. For B. cereus, the PlcR-dependent expression of
multiple toxins has been described, including the non-
haemolytic enterotoxin (Nhe), which is a three-component
toxin associated with food poisoning (Lund & Granum,
1996). B. anthracis is known to express NheA in a
PlcR-independent manner (Mendelson et al., 2004), yet it
is likely that activation of PlcR increases expression, since its
promoter harbours a PlcR box. Concomitantly, we found
NheA(BA1887)inthesupernatantofB.anthracisexpressing
PlcR. Many other toxins and virulence factors, including
proteases and phospholipases, are dependent on PlcR
(Gohar et al., 2002), and all of them could contribute to
toxicity towards macrophages. The specificity with which
the macrophage population was targeted in our in vivo
studies was surprising, indicating a crucial role for these
cells. PlcR is truncated in all known B. anthracis strains to
date, and silencing of these unknown toxin(s) that mediate
macrophage killing could be the reason why mutation of
PlcR was favoured in these strains. The exact mechanism by
which PlcR-reconstituted B. anthracis attacks macrophages
and the identity of the toxin(s) involved deserve further
investigation, especially in strains harbouring both virulence
plasmids.
Fig. 6. In vivo macrophage toxicity of proteins secreted by Bacillus. (a) Intraperitoneal (IP) washes of mice (n52) treated with
500 ml filter-sterilized bacterial culture supernatants derived from B. anthracis or B. anthracis anthrolysin knockout strain in the
presence or absence of PlcR–PapR. Control animals were treated with BHI broth alone. (b) Flow cytometry analysis showing
forward and side scatter of IP washes derived from mice treated with cell-free bacterial culture supernatants. Arrows indicate
macrophage (F4/80+) populations lacking in washes treated with supernatants derived from PlcR–PapR-expressing bacteria.
(c) Chart of macrophage (F4/80+) populations present in IP washes of mice treated with bacterial supernatants or with BHI
alone. (d) Quantification of macrophages (%) present in the IP washes of mice treated with bacterial culture supernatants.
Percentages represent the number of F4/80+ cells relative to the entire cell population present in the IP wash. Shown are
mean±SD from one representative experiment out of three.
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